GlaxoSmithKline PLC (GSK) — Cash Flow Quality Index
GlaxoSmithKline PLC (GSK) has a Cash Flow Quality Index of 1.04x as of September 2025. Operating cash flow of GBX2.22 Billion exceeds net income of GBX2.14 Billion, indicating high earnings quality where cash backs reported profits. Explore cash flow conversion of GlaxoSmithKline PLC to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
GlaxoSmithKline PLC Cash Flow Quality Index (1990–2024)
Historical Cash Flow Quality Index for GlaxoSmithKline PLC across 40 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check GlaxoSmithKline PLC investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for GlaxoSmithKline PLC (1990–2024)
Year-by-year earnings quality comparison for GlaxoSmithKline PLC. For live market cap and the full company financial profile, see GlaxoSmithKline PLC market capitalisation.
| Year | Quality Index | Operating CF (GBX) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.22x | GBX6.55 Billion | GBX2.95 Billion | ▲ +61.7% |
| 2023 | 1.37x | GBX6.77 Billion | GBX4.93 Billion | ▼ -8.7% |
| 2022 | 1.50x | GBX7.40 Billion | GBX4.92 Billion | ▼ -3.6% |
| 2021 | 1.56x | GBX7.95 Billion | GBX5.10 Billion | ▲ +18.1% |
| 2020 | 1.32x | GBX8.44 Billion | GBX6.39 Billion | ▼ -13.2% |
| 2019 | 1.52x | GBX8.02 Billion | GBX5.27 Billion | ▼ -26.9% |
| 2018 | 2.08x | GBX8.42 Billion | GBX4.05 Billion | ▼ -34.7% |
| 2017 | 3.19x | GBX6.92 Billion | GBX2.17 Billion | ▼ -47.9% |
| 2016 | 6.12x | GBX6.50 Billion | GBX1.06 Billion | ▲ +1893.7% |
| 2015 | 0.31x | GBX2.57 Billion | GBX8.37 Billion | ▼ -83.2% |
| 2014 | 1.83x | GBX5.18 Billion | GBX2.83 Billion | ▲ +42.5% |
| 2013 | 1.28x | GBX7.22 Billion | GBX5.63 Billion | ▲ +39.1% |
| 2012 | 0.92x | GBX4.38 Billion | GBX4.74 Billion | ▼ -19.5% |
| 2011 | 1.15x | GBX6.25 Billion | GBX5.46 Billion | ▼ -68.8% |
| 2010 | 3.67x | GBX6.80 Billion | GBX1.85 Billion | ▲ +165.2% |
| 2009 | 1.38x | GBX7.84 Billion | GBX5.67 Billion | ▼ -10.9% |
| 2008 | 1.55x | GBX7.31 Billion | GBX4.71 Billion | ▲ +103.3% |
| 2007 | 0.76x | GBX5.79 Billion | GBX7.59 Billion | ▲ +50.6% |
| 2006 | 0.51x | GBX3.96 Billion | GBX7.81 Billion | ▼ -37.6% |
| 2005 | 0.81x | GBX5.59 Billion | GBX6.87 Billion | ▼ -1.9% |
| 2004 | 0.83x | GBX4.77 Billion | GBX5.76 Billion | ▲ +8.8% |
| 2003 | 0.76x | GBX4.85 Billion | GBX6.38 Billion | ▲ +38.0% |
| 2002 | 0.55x | GBX3.06 Billion | GBX5.55 Billion | ▼ -43.3% |
| 2001 | 0.97x | GBX4.61 Billion | GBX4.74 Billion | ▲ +148.0% |
| 2000 | 0.39x | GBX1.85 Billion | GBX4.73 Billion | ▲ +101.6% |
| 1999 | 0.19x | GBX510.00 Million | GBX2.62 Billion | ▲ +27.1% |
| 1998 | 0.15x | GBX410.00 Million | GBX2.68 Billion | ▼ -29.9% |
| 1997 | 0.22x | GBX615.00 Million | GBX2.82 Billion | ▼ -19.6% |
| 1996 | 0.27x | GBX849.00 Million | GBX3.13 Billion | ▼ -48.4% |
| 1995 | 0.53x | GBX1.25 Billion | GBX2.38 Billion | ▼ -77.7% |
| 1995 | 2.36x | GBX2.45 Billion | GBX1.04 Billion | ▲ +0.0% |
| 1994 | 2.36x | GBX2.45 Billion | GBX1.04 Billion | ▲ +306.6% |
| 1994 | 0.58x | GBX1.05 Billion | GBX1.82 Billion | ▲ +0.0% |
| 1993 | 0.58x | GBX1.05 Billion | GBX1.82 Billion | ▼ -4.7% |
| 1993 | 0.61x | GBX927.00 Million | GBX1.52 Billion | ▲ +0.0% |
| 1992 | 0.61x | GBX927.00 Million | GBX1.52 Billion | ▲ +19.1% |
| 1992 | 0.51x | GBX657.00 Million | GBX1.29 Billion | ▲ +0.0% |
| 1991 | 0.51x | GBX657.00 Million | GBX1.29 Billion | ▼ -8.4% |
| 1991 | 0.56x | GBX615.00 Million | GBX1.10 Billion | ▲ +0.0% |
| 1990 | 0.56x | GBX615.00 Million | GBX1.10 Billion | — |